Rhenman & Partners Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-280,000
| Closed | -$6.66M | – | 97 |
|
|
2023
Q1 | $6.66M | Sell |
280,000
-150,000
| -35% | -$3.57M | 0.73% | 47 |
|
|
2022
Q4 | $9.21M | Buy |
430,000
+65,000
| +18% | +$1.39M | 0.96% | 40 |
|
|
2022
Q3 | $8.73M | Buy |
365,000
+115,000
| +46% | +$2.75M | 0.91% | 42 |
|
|
2022
Q2 | $2.41M | Sell |
250,000
-10,000
| -4% | -$96.2K | 0.27% | 75 |
|
|
2022
Q1 | $4.38M | Sell |
260,000
-90,000
| -26% | -$1.51M | 0.43% | 67 |
|
|
2021
Q4 | $5.75M | Hold |
350,000
| – | – | 0.38% | 66 |
|
|
2021
Q3 | $5.68M | Buy |
+350,000
| New | +$5.68M | 0.4% | 68 |
|
|
2017
Q3 | – | Sell |
-23,920
| Closed | -$61K | – | 111 |
|
|
2017
Q2 | $61K | Hold |
23,920
| – | – | 0.01% | 107 |
|
|
2017
Q1 | $88K | Hold |
23,920
| – | – | 0.01% | 103 |
|
|
2016
Q4 | $116K | Buy |
+23,920
| New | +$116K | 0.02% | 107 |
|